Side-by-side comparison of AI visibility scores, market position, and capabilities
Hotel metasearch platform majority-owned by Expedia Group; €485M revenue in 2023. Compares hotel prices across 180+ OTAs and booking sites.
Trivago is a hotel price comparison and metasearch platform founded in 2005 in Düsseldorf, Germany. Acquired by Expedia Group in 2012, Trivago went public on Nasdaq in 2016 in one of Germany's largest tech IPOs of that year. The platform allows travelers to compare hotel prices across 180+ OTAs and booking sites in real time, covering over 5 million hotels, apartments, and alternative accommodations worldwide. Trivago's brand is built on its iconic TV advertising campaigns across 55 countries.\n\nTrivago generates revenue through a CPC (cost-per-click) model, charging advertisers—primarily OTAs and hotel chains—for qualified hotel shopper referrals. Its referral auction system ranks advertiser bids alongside relevance signals to determine listing order. Trivago has invested in a hotel profile platform that allows hotel owners to manage their public-facing content and pricing directly.\n\nTrivago reported annual revenue of €485M (~$522M) in 2023. Expedia Group owns approximately 65% of Trivago. The company has undergone restructuring to reduce dependency on performance marketing and increase direct and organic traffic. As of 2025, Trivago operates in 55 countries and 33 languages, with mobile apps accounting for a growing share of its qualified referral traffic.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.